Ticagrelor Synthesis via Triazolopyrimidine Intermediate

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing synthesis methods for ticagrelor are lengthy and involve the use of toxic compounds, with poor chemoselectivity issues and the need for heavy metal catalysts, making them inefficient and economically unfeasible for industrial production.

Innovation Solution

A process involving the use of a compound of formula VI or its salt, which allows for a shorter synthesis by omitting the deprotection step and using non-toxic, basic reagents, enabling the introduction of a hydroxyethyl side chain in 2-3 steps and facilitating the production of ticagrelor with improved purity through one-pot conversions and solid crystalline intermediates.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If existing synthesis methods are used, then ticagrelor can be produced, but the synthesis is lengthy (7-9 steps) and involves toxic compounds

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidtoxicity
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and removes toxic elements (CHBr3, triflic anhydride, heavy metal catalysts) and lengthy synthesis steps from the process by introducing a novel compound of formula VI that enables direct reaction without protective group deprotection, thereby eliminating harmful substances and reducing synthesis steps to 4-5 steps

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces expensive and toxic reagents (triflic anhydride, CHBr3, heavy metal catalysts like Pd/C and Pt/C) with inexpensive, non-toxic alternatives (compound of formula VI, basic reagents), making the process economically feasible and environmentally friendly for industrial production

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Productivity

If existing synthesis methods are used, then ticagrelor can be produced, but poor chemoselectivity issues arise

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidchemoselectivity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention applies local quality by designing compound of formula VI with specific functional group characteristics that enable selective reaction at the desired site without affecting other parts of the molecule, achieving high chemoselectivity in the formation of key intermediates and avoiding side reactions

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent changes the chemical parameters by introducing compound of formula VI with modified structural parameters (protective group configuration) that alter the reactivity profile, enabling selective reactions under basic conditions and improving chemoselectivity throughout the synthesis pathway

Inventive Principle:
Principle #35Parameter changes

3Productivity

If existing synthesis methods are used, then ticagrelor can be produced, but heavy metal catalysts are required

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidheavy metal contamination
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The invention extracts and eliminates heavy metal catalysts (Pd/C, Pt/C) from the synthesis process by designing a reaction pathway that uses basic reagents and compound of formula VI, which proceeds without requiring metal catalysis, thereby producing ticagrelor free from heavy metal contamination

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces expensive heavy metal catalysts with inexpensive basic reagents and compound of formula VI, eliminating the need for costly metal catalysts while maintaining synthesis efficiency and producing a cleaner product suitable for pharmaceutical applications

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Productivity

If existing synthesis methods are used, then ticagrelor can be produced, but the process is economically unfeasible for industrial production

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoideconomic feasibility
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The invention replaces expensive reagents (triflic anhydride, CHBr3, heavy metal catalysts, deprotection reagents) with inexpensive alternatives (compound of formula VI, basic reagents), dramatically reducing material costs and making the process economically viable for large-scale industrial production

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent extracts and removes costly synthesis steps (protective group deprotection, toxic reagent handling, metal catalyst recovery) by introducing compound of formula VI that enables direct reaction, thereby simplifying the process and reducing both operational and material costs for industrial manufacturing

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process significantly reduces the number of reaction steps, eliminates the use of toxic substances, and enhances the purity of ticagrelor by avoiding side product formation and stereoisomeric impurities, resulting in an industrially applicable and economically improved method for producing ticagrelor.

Implementation Method 1

converting a compound of formula VIII by nitrosation to a compound of formula IX

Methodology Applied
Scientific EffectNitrosation:

Implementation Method 2

coupling the compound of formula IX or IX' with a compound of formula X or a salt thereof in a presence of a base to provide a compound of formula XI

Methodology Applied
Scientific EffectNucleophilic aromatic substitution:

Data Source

PatentEP2794575B1Synthesis of triazolopyrimidine compounds
Publication Date: 2018.12.05 LEK PHARMA D D
  • EP2794575B1 patent drawing
  • EP2794575B1 patent drawing
  • EP2794575B1 patent drawing

AI summary

The present invention relates to the field of organic synthesis and describes the synthesis of specific intermediates suitable for the preparation of triazolopyrimidine compounds such as ticagrelor.